Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P[R]EBEN Study in Relapsed Aggressive Non-Hodgkin Lymphomas
NCT02678299Phase 2Active, not recruiting
- Sponsor
- Aarhus University
- Start
- Feb 2016
- Primary completion
- Feb 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 5
01
Overview
A Phase 2 trial of pixantrone in non-Hodgkin lymphoma (NHL), sponsored by Aarhus University. Started Feb 2016; status: active, not recruiting.
02
Drugs
pixantrone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02678299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678299.